BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) investors concerning the Company and its officers’ potential violation of federal securities laws.
On February 23, 2017, Boston Scientific disclosed the voluntary recall of the Company’s Lotus Valve heart devices. Citing issues with the premature release of a pin, Boston Scientific believes the problem is due to "excess tension in the pin mechanism introduced during the manufacturing process." Additionally, the Company doesn’t expect to bring the product back to market until the fourth quarter of 2017.
On this news, shares of Boston Scientific fell as much as 7% during intraday trading on February 23, 2017.
If you purchased Boston Scientific securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.